An adequate circulating blood volume is recognized to be important after open-heart surgery (Carr, Sloan, and Tovar, 1960 (Flanagan, Steinmetz, Crawford, and Merendino, 1964) , internal redistribution of functional extracellular fluid by plasma exudation occurring after any form of major surgery (Berger, Boyd, and Marcus, 1964) , or to the homologous blood syndrome, in which there is a shift of blood from the extracorporeal circuit into the patient during perfusion and a measurable blood deficit post-operatively (Gadboys, Slonim, and Litwak, 1962; Litwak, Slonim, Wisoff, and Gadboys, 1963) . One investigation showed no discrepancy in the volumes estimated by clinical and isotope methods (Theye and Kirklin, 1963) . The use of haemodilution and plasma expanders during and after cardiopulmonary bypass introduces new factors in blood volume change (Ankeney, Renner, Leverett, and Beheler, 1965) which call for measurement. The advent of a rapid, semi-automatic system (Williams and Fine, 1961) has permitted more accurate control of replacement therapy (Berger et al., 1964; Flanagan et al., 1964) ; whether the method is reliable in the presence of dextran or could be used during perfusion has not been previously determined.
An attempt has been made to evaluate these issues. It has proved possible to provide during perfusion sufficiently stable conditions of flow rate, blood loss, and distribution of blood between the patient and the extracorporeal circuit to carry 'Present address: Princess Beatrice Hospital, Old Brompton Road.
Earl's Court, London S.W.5 out studies of red cell and plasma volumes during bypass, particularly with low molecular weight dextran (LMWD) haemodilution. The postoperative blood volume studies on some of these patients will be reported separately.
PROTOCOL
The effect of LMWD on standard radioactive methods of red cell and plasma determinations was established in a group of patients who were recovering from thoracic surgery not involving bypass. These also served as a comparative control series for post-operative observations. All patients who underwent isotope investigations gave personal consent during the experimental period.
Changes of blood volumes during standard perfusion were studied using haemodilution with LMWD, and these were compared with the effects of perfusion using 5% dextrose solution in part, or whole blood for perfusion.
METHODS
GROUP I Six patients who were undergoing thoracic surgery without perfusion had initial red cell and plasma volume determinations made over 30 to 65 minutes immediately following the induction of anaesthesia. Blood loss and replacement during surgery and recovery was on a volumefor-volume basis with additional transfusion based on the clinical estimation of loss on drapes and weighed swabs. When the post-operative loss observed by pleural drainage was small, some two to four hours after return to the ward, and when the patient was considered to have been in a satisfactory blood balance state for at least two hours, 500 ml. 10% LMWD2 in 0.9% sodium chloride was transfused over 60 to 90 minutes. Any small continuing chest drainage during infusion was matched by donor blood.
After the measurement of sample background radioactivity, a second simultaneous doubleisotope injection study was carried out on completion of the LMWD infusion, and equilibration studies were made up to 140 minutes. Isotope injection was through a wide-bore indwelling needle used for transfusion; samples were withdrawn from a catheter placed in the contralateral antecubital vein.
GROUP II Plasma and red cell equilibration curves and volume changes were investigated before and during cardiopulmonary bypass in 16 patients. Initial observations were begun on a larger and unselected series of patients submitted to cardiac surgery. Clinical exigencies, unbalanced blood losses associated with cannulation or cardiotomy or occurring during blood volume studies, or obligatory changes in perfusion, necessitating exclusion from the series, resulted in a marked bias of patients with the simpler cardiac problems. First estimations followed sampling for background radioactivity and the induction of anaesthesia before thoracotomy. Isotopes were injected intravenously through a fine polyvinyl chloride catheter used for monitoring, which was then thoroughly flushed, and samples were withdrawn from a brachial artery catheter after first clearing it, usually at 10-minute intervals from 10 minutes after isotope injection. Blood loss until perfusion was measured (swab weighing and suction); any intravenous administration was restricted to dextrose 5% whenever possible (shown as 'clear fluid' in the tables). Necessary blood replacement was noted, and its red cell and plasma components were calculated after correction of a sample haematocrit for trapped plasma (Chaplin and Mollison, 1952) . In three patients there was measurable bleeding after the start of perfusion and before the second blood volume studies. This also was not replaced, therapy being confined to an intentional shift of the perfusate from the machine to the patient to compensate. All losses were calculated in terms of red cell and plasma portions by correction of a sample haematocrit for trapped plasma. During perfusion all blood appearing in the cardiotomy site was rapidly returned to the heart-lung circuit to avoid mechanical sequestration. Severe blood loss before perfusion (except in case 14, in whom it was over a prolonged period and was apparently well balanced by transfusion as it occurred), unmeasurable loss on to drapes of more than a very small amount, or bleeding during the period of blood volume study called for elimination from the series. The duration of perfusion of some of the simpler cases was lengthened slightly to allow completion of the studies.
Perfusion was by means of cardiopulmonary bypass using rotating disc' or disposable bubble2 oxygenators; the type used was randomly distributed over the patients left in the series and appeared insignificant in the study. A heat exchanger in circuit ensured normothermia, and the priming volume of the circuit ranged from 2,000 to 4,000 ml.; this was not related to the patient's weight but to the requirements of the circuit. Priming volumes, including any residual volume of solution used in preliminary calibration, and solutes used to carry medication were accurately measured. A sample haematocrit, corrected for trapped plasma, was used to determine the constituent red cell and plasma volumes. Partial bypass was commenced at about half the ultimate flow, which was in excess of 2-4 1./m. i / min., and reached in about 60 to 90 seconds. Full flow rate, once achieved, was not altered during the period of study.
From recorded losses before a second blood volume determination, blood replacement, and priming volume measurements, the 'anticipated volume' of the combined patient-extracorporeal circulation was calculated on a simple additionsubtraction basis.
PRIMING In all systems there was a measured residuum of 5% dextrose after pump calibration (200 to 400 ml.) and also the water content of heparin, calcium chloride, and 8-4 % sodium bicarbonate (50 to 60 mEq). The remainder of the priming volume was made up as follows:
Group II A: 20 ml./kg. 10% Rheomacrodex in 0 9% sodium chloride, the remaining necessary prime being 1,500 to 2,000 ml. cross-matched, 48-hour-old blood containing 30 ml. Edgludate per 500 ml.
Group II B: 20 ml./kg. 5% dextrose solution, the remainder being blood as in group II A. Group II C: 48-hour-old blood with Edgludate preservative.
About 4 minutes after the start of perfusion, 2 to 3 minutes' total cardiac bypass, a sample was taken for background radioactivity. Radioactive chromium-labelled erythrocytes and iodinelabelled plasma were then simultaneously injected 'Osborn-Bramson-Gerbode or Melrose models 2Rygg into the venous line of the heart-lung machine, and samples were taken from the arterial line of the circuit at 5-minute intervals from 5 to 25 minutes. Since radioactivity from the first estimation was markedly diluted by mixing of the extracorporeal fluid, it was not necessary greatly to increase radioactive dosages for this estimation. Post-operative studies were made on the same patients when possible and will be subsequently reported.
In group II A (Rheomacrodex), serum LMWD concentrations were measured in eight patients and serum proteins in three patients.
In eight patients, not otherwise part of this study, variations of (peripheral) haematocrit of simultaneous samples taken from available sites during perfusion were compared (monitor lines in superior and inferior venae cavae, brachial artery, and the venous and arterial lines of the heart-lung machine) to exclude significant effects of the sampling site.
Red cell and plasma volume estimations were made from the simultaneous injection of 51Cr-labelled erythrocytes and 1311-labelled albumin. Red cells were tagged by the method of Mollison and Veall (1955) . The patient's blood, 15 to 20 ml. in 5 to 10 ml. ACD solution, was centrifuged, the plasma removed, and radioactive sodium chromate added to the cells, which were then incubated at room temperature for 20 minutes with gentle agitation every 5 minutes. They were then washed three times in saline before final suspension in 12 to 13 ml. saline. For normal range (0-91 is commonly used as a factor).
There is little change in the ratio after Rheomacrodex infusion. Table V shows haematocrits of simultaneous samples from a number of sites available during perfusion in a different series of patients. Samples for blood volume studies are more easily taken from the extracorporeal sites, since it is undesirable to interrupt the continuous use of intravascular catheters for monitoring. There is no evidence that sampling from extracorporeal, rather than intravascular, sites during perfusion will significantly affect the volumetric calculations.
GROUP II Labelled plasma and red cell equilibration curves are shown before and during perfusion in cases where LMWD was used (group II A, Fig. 3 ) and where 5% dextrose was used (group II B) or whole-blood priming (group II C, Fig. 4) .
Red cell equilibration appears acceptable and complete within 10 minutes in all groups before perfusion. The method of injection during perfusion, into the circuit venous line, provides conditions of early and thorough mixing within the oxygenator, and earlier observations had suggested that when partial heart-lung bypass at high flow rates is established for 2 minutes, red cell mixing is complete (Raison, 1963) . This rapidity of mixing during perfusion has been borne out by the speed of stabilization of haematocrit during haemodilution perfusion (Raison, Noronha, and Skuse, in preparation Clinically, an attempt was made in each case to maintain proper partition of the mixed volume between the patient and the heart-lung machine, securing unchanged venous pressure from that before bypass, with an acceptable arterial pressure. This is commonly thought to be the best means of maintaining an unchanged blood volume within the patient. In group II A this resulted in no shift of blood from the oxygenator, or a small apparent gain (cases 5, 11, and 12); the influence of addition to the oxygenator from temporarily emptied heart cavities was excluded. In groups II B and II C there was an observed loss of perfusate from the machine into the patient, more rapid in group II C (whole blood). Where loss of blood occurred during perfusion it was compensated by allowing a lesser volume in the machine rather than in the patient.
From these data, together with corrections for volumes withdrawn for sampling and water injected, it was possible to calculate the 'anticipated volumes' of red cells, plasma, and blood shown in Table VII In spite of clinical limitations the results are amenable to statistical analysis. The 'anticipated volumes' of cases perfused with LMWD (group II A) were first compared with the combined groups II B and C (dextrose 5% and whole blood). The difference between the means for plasma volume is 4,633 2-4,663-2==30 0 ml., which is negligible, whereas that between red cell volumes is 1,908 2-2,156 8=248 6 ml., which, although not significant, is more than 10%. This can be accounted for largely by the different prime in groups II B and C. This analysis indicates that the two groups were initially comparable.
As there is considerable variation between individual readings, it is necessary to take the base line of each into account in calculation. Calculating the proportion measured/anticipated volume for each component in each patient yields highly significant differences.
Rheomacrodex priming produces a notable increase of plasma volume compared with a reduction when either of the other primes was used (P<0-001). There is also a difference in the red cell volumes, there being a possible slight gain in the LMWD group and a definite loss in the other two groups (P<0 01). The resultant total blood volume increases in group II A and disappearances in groups II B and II C are also significantly different (P<0-001).
In spite of the small number of cases, the differences are similarly significant when comparing the plasma expansion of LMWD priming (II A) and plasma loss with whole blood (II C), and when comparing the preservation of red cell volumes in group II A with erythrocyte disappearance in group II C. (Raison, 1962) and there is no apparent relation between the dextran con- centration and either the pump priming volume or the combined circulating volume ('anticipated volume'). Some levels are below those regarded as minimal for effective prevention of microcirculatory red cell aggregation (1,200 to 2,000 mg./100 ml.) or those found by Long, Sanchez, Varco, and Lillehei (1961) during perfusion (1,400 to 1,600 mg./100 ml.). Nor are serum concentrations directly related to the plasma volume expansion found. They are moderately well maintained over the short periods investigated. Serum proteins, once diluted by LMWD, are stable. A number of subsequent observations have confirmed this. In the early period studied, there do not appear to be variations of the major oncotic influences during perfusion.
The haematocrit ratio changes are shown in Table IX . The pre-perfusion mean correction factor for all three groups is 0-91 (S.D.+0±054). During bypass, the mean correction factor for the combined groups is 0-96 (S.D. + 055), that for group II A alone 0 99 ( ± 0-45), and for group II C (whole blood, the least haemodilution) 0-92 + 0 34. These figures are not significant, having regard to the small numbers and to the small variations of peripheral haematocrit found at different sites in perfusion (Table V) .
DISCUSSION
It is possible to carry out blood volume measurements during perfusion; previous estimations have been based on changes in venous pressure (Kaplan, Edwards, Helmsworth, and Clark, 1960) . The notable clinical advantages of Rheomacrodex (Raison, 1965) determined that the investigation was principally to assess the effect of this haemodiluent. Since the study was of stable conditions during early perfusion, the major hazard to such estimations, that of considerable oozing and unmeasurable loss in drapes, was not of consequence in this series.
In two of the LMWD group, plasma expansion was unexpectedly large. Case 5 was an obese young woman with some unexplained ankle oedema. Cellular osmolality may be a factor in determining expansion. None of the volume determinations was available to the clinician; the expansion in case 12 might have been of practical significance. This was a small patient with cyanotic tetralogy of Fallot whose haematocrit fall during bypass was regarded as satisfactory. Venous pressure was maintained at its preperfusion value, and although it was appreciated that there was some increase of volume within the oxygenator, the retrospective clinical impression was that it was by no means as great as 1,000 ml. The patient was presumably obliged to accommodate a significant part of this expansion. Almost identical observations were made in another small patient with tetralogy of Fallot before the present studies were started, and the findings were then regarded as chance, being then isolated. 10% Rheomacrodex has initially a water-binding capacity of approximately its own volume on rapid infusion (Davies, Ricketts, and Williams, 1963 Erythrocyte volume determinations using the semi-automatic method' are based on sample haematocrit and do not usually take account of variations due for trapped plasma and for peripheral:whole body haematocrit ratio. The latter appears to change during perfusion in an upward direction (Table VII) , though not significantly. It is possible that the proportion of trapped plasma is altered in haemodilution, especially by LMWD with its property of altering red cell suspension stability. This matter has not yet been investigated. The factor of alteration in haematocrit due to red cell swelling with pH change (Carrier, Douglas, and Crowell, 1964) has been ignored. Such corrections are, however, small, and calculations of blood volume and red cell mass during perfusion, based solely on plasma activity counts and a formally corrected haematocrit (X 0 91), are extremely close to those obtained by the double-isotope technique, except in case 4, where the unexplained high red cell volume disturbs the relationship. It is therefore possible to use the Volemetron method during perfusion.
In two (cases 14 and 15) of the four cases perfused with 'whole blood', the recorded red cell and plasma disappearances are in the proportion of the haematocrit. Even in this group there is some dilution of perfusate from water retained after calibration, from medication, and from the Edgludate solution present. These elements may provide the relatively higher plasma loss seen in the other two cases (cases 13 and 16). These findings support the clinical observation of the disappearance of blood into the patient during perfusion by homologous blood (Gadboys et al., 1962; Litwak et al., 1963) noted by others, including us (Raison, 1962) . It is surprising that, in the only two cases which received dextrose 5%, there should be a disappearance of red cells of the same order as in group II C, while the loss of plasma is small. The loss in circulating volume observed clinically with whole blood perfusion occurs within the first few minutes. Volu1Volemetron, Ames Atomium Ltd. metric calculations suggest that 5% dextrose with whole blood results in only a small loss of plasma during brief perfusion. The number of cases studied, however, is too small to comment reliably on the rate at which the total circulating volume reduces with dextrose 5%, as the water, unheld by colloid, disappears into the tissues and is more rapidly excreted during perfusion due to the much greater osmotic diuresis induced by dextrose 5% compared with Rheomacrodex. The perfusate shrinkage is, however, seen clinically and occurs more slowly than with whole blood. When dextrose alone is used to prime the circuit, further solution has usually to be added to maintain apparent volume, usually within the first 10 to 20 minutes.
This study provides evidence of the sequestration of blood during homologous blood perfusion and of red cells with dextrose perfusion, and demonstrates the protective effect of Rheomacrodex (not merely by plasma expansion but by preventing this sequestration). It fails to demonstrate the existence of a slowly circulating red cell mass. The clinically improved peripheral perfusion seen with LMWD and its prevention of sequestration suggested a link with the work of Shoemaker and lida (1962) in the other two groups, so that it would not be the site of the non-circulating volumes found in the whole blood or dextrose-blood groups. In addition, since complete mixing of the circulation is obtained within 2 minutes on partial perfusion (Raison, 1963) , plasma volume expansion from LMWD will also be complete during partial bypass. Isotope injection and sampling during perfusion were made after the institution of total bypass, so that the large measured plasma volume increases in the LMWD series would not include a further volume supposedly sequestered in the lungs. This would require an altogether excessive total plasma expansion and, since such sequestration would be of plasma and red cells, a total increase of red cells on initial mixing greater than the small increase actually noted (which is probably insignificant). If there is 'partial sequestration' (the presence of a slowly circulating volume) in any of these areas, it should lead to a slope in the 5 Cr equilibration curves during perfusion, if significant, and there might be a difference in the slopes of groups II B and II C compared with group II A if, in the latter, LMWD increased the rate of equilibration from these body masses. The sequestration observed with whole blood and dextrose-and-blood is total (non-circulating volume).
It appears, therefore, that whereas a simple solution may improve the clinical features of perfusion by mere haemodilution, the advantage of LMVWD is that it can fix the haemodilution over a period of time and also prevent red cell or whole blood sequestration. The volume lost from the circulation, and the proportion of the vascular bed rendered inactive by this loss, during blood or blood-dextrose perfusions may be small and tolerable in brief perfusions but of greater significance with the demand for long-term circulatory support in conditions where peripheral stagnation is already probable. The effects of adding albumin to dextrose dilution or of using plasma have not been investigated. Albumin is not readily available in Britain, plasma may bear additional dangers, and both would cost more than LMWD. Whether LMWD should be used as a 10% solution, when it may take up water from the tissues, or in such dilution as will render the perfusate isoncotic (Roe, Swenson, Hepps, and Bruns, 1964 ) has yet to be established, and this must be correlated with the serum concentration necessary to prevent intravascular sludging and sequestration.
SUMMARY
Simultaneous, separate red cell and plasma volume measurements have been carried out in a limited number of clinical cases during controlled conditions of cardiopulmonary bypass.
The effects of low molecular weight dextran as part of the extracorporeal circuit prime have been compared with those of haemodilution with 5% dextrose and those of whole-blood priming.
Low molecular weight dextran causes plasma volume expansion and maintenance of the red cell volume.
Haemodilution by dextrose 5% is confined to that of its own volume during brief perfusion and is associated with red cell disappearance.
Whole-blood perfusion is associated with a reduction of both red cell and plasma masses below those anticipated.
The technique has failed to establish the occurrence of delayed red cell equilibration in the period studied, but suggests the presence of a non-circulating blood volume when whole blood or haemodilution with dextrose 5% are used, and demonstrates prevention of this sequestration by LMWD. 
